|
|
|
|
|
|
|
|
|
|
|
26.02.26 - 10:00
|
WPP FY25 Headline Operating Profit Declines (AFX)
|
|
|
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - WPP (WPPGY, WPP.L) reported preliminary fiscal 2025 pretax profit of 131 million pounds compared to 1.03 billion pounds, prior year. Loss per share was 20.0 pe......
|
|
|
26.02.26 - 09:18
|
WPP to merge ad agencies and cut jobs in radical shake-up to counter AI threat (The Guardian)
|
|
|
Group aims to be 'simpler, lower-cost, AI-enabled business' and achieve £500m of annual savings by 2028The beleaguered advertising group WPP has announced a radical restructure to counter the threat posed by the AI revolution, including merging its ad agencies and cutting jobs.Aiming to be “a simpler, lower-cost, AI-enabled business”, the London-based company laid out plans to achieve £500m of annual savings by 2028, at a cost of £400m over two years. Continue reading......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.01.26 - 21:06
|
Bottle Rocket Appoints Matt Smith as President (PR Newswire)
|
|
|
DALLAS, Jan. 14, 2026 /PRNewswire/ -- Bottle Rocket, a leading digital product agency and part of the WPP worldwide network, today announced that Matt Smith has been appointed President, effective immediately. Matt, an experienced leader who has built strong client relationships, driven......
|
|
|
13.01.26 - 23:36
|
Blue Matter ergänzt neue Fähigkeiten in der biopharmazeutischen Forschung und Entwicklung unter der Führung von Partnerin Tara Austraat-Churik (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Blue Matter hat einen neuen Praxisbereich gegründet, der auf die Bedürfnisse von Kunden aus der biopharmazeutischen Forschung und Entwicklung (FuE) ausgerichtet ist. Geleitet wird der Praxisbereich von Tara Austraat-Churik, einer Partnerin, die seit September 2025 für Blue Matter tätig ist.
Tara Austraat-Churik ist bereits seit über 20 Jahren für Life-Science-Kunden tätig. Ihre Schwerpunkte sind Strategieentwicklung und -umsetzung, Betriebsmodell- und Organisationsgestaltung sowie Prozessoptimierung in den Bereichen Forschung und Entwicklung sowie Medical Affairs. Bevor sie zu Blue Matter wechselte, war sie als Managing Director im Bereich Forschung und Entwicklung, Gesundheit, Wissenschaft und Wellness bei EY tätig. Sie bringt umfangreiche Erfahrungen im Consulting-Bereich mit, die sie unter anderem bei Booz Allen Hamilton, Navitas, WPP und IBM sammeln konnte. Sie hat einen BA- und MA-Abschluss der University of Notre Dame und einen MSc-Abschluss in translationaler Medi...
|
|
|
13.01.26 - 15:03
|
Blue Matter Establishes New Capabilities in Biopharma Research & Development Led by Partner, Tara Austraat-Churik (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Blue Matter is pleased to announce that it has established a practice area dedicated to serving clients in biopharmaceutical Research & Development (R&D). The practice is led by Tara Austraat-Churik, a Partner who joined the firm in September 2025.
Tara Austraat-Churik has been serving life science clients for more than 20 years. Her areas of expertise include strategy development and implementation, operating model and organizational design, and process optimization in R&D and Medical Affairs. Prior to joining Blue Matter, she served as Managing Director in R&D, Health, Science, and Wellness at EY. She has a robust background in consulting, which also includes roles at Booz Allen Hamilton, Navitas, WPP, and IBM. She holds a BA and MA from the University of Notre Dame and an MSc in Translational Medicine from the University of Edinburgh.
The R&D practice, according to Austraat-Churik, exists to help biopharma companies simplify and accelerate the pathway to market. She adds, “...
|
|
|
|